Articles

RSS

Patheon , a global provider of drug development and manufacturing services to the international pharmaceutical industry, announced recently that it has signed a master service agreement with Omnicare Clinical Research, a leading global CRO, for distribution of clinical trial materials in Europe and Asia Pacific.

Under the terms of the agreement, Omnicare Clinical Research's clinical supplies division will provide Patheon's customers with various clinical supply services that include monitoring, distribution and return accountability. The agreement now enables Patheon to provide a broader clinical materials service to its clients.

Dr. Colin Minchom, Patheon's Vice President for Pharmaceutical Development Services, North America, stated, "We are excited to expand our expertise and development and clinical packaging capabilities with assistance from Omnicare Clinical Research. By leveraging Omnicare Clinical Research's strengths, we're able to provide Patheon's clients with a greater variety of manufacturing and packaging options, including distribution locations for clinical trial materials in Europe and Asia Pacific."

About Patheon
Patheon Inc. (www.patheon.com) is a leading global provider of contract development and manufacturing services to the global pharmaceutical industry. Patheon prides itself in providing the highest quality products and services to more than 300 of the world's leading pharmaceutical and biotechnology companies. Patheon's services range from preclinical development through commercial manufacturing of a full array of dosage forms including parenteral, solid, semi-solid and liquid forms. Patheon uses many innovative technologies including single-use disposables, Liquid-Filled Hard Capsules and a variety of modified release technologies.

Patheon's comprehensive range of fully integrated Pharmaceutical Development Services includes pre-formulation, formulation, analytical development, clinical manufacturing, scale-up and commercialization. Patheon can take customers direct to clinic with global clinical packaging and distribution services and Patheon's Quick to Clinic™ programs can accelerate early phase development project to clinical trials while minimizing the consumption of valuable API. Patheon's integrated network strives to ensure that customer products can be launched with confidence globally.

About Omnicare Clinical Research
Headquartered in King of Prussia, PA, Omnicare Clinical Research provides clinical development services to pharmaceutical, biotechnology, nutraceutical and medical device companies through its office locations in 30 countries worldwide. As a premier Phase I-IV contract research organization, Omnicare Clinical Research features diverse therapeutic expertise and a comprehensive scope of clinical service offerings. Additionally, the company is an industry leader in geriatrics-focused drug studies. Omnicare Clinical Research focuses on providing clients with a superior drug development experience through strong project management, exceptional service and proactive solutions. The company is a subsidiary of Omnicare, Inc., a leading provider of pharmacy services to long-term care facilities and other chronic care settings comprising nearly 1.4 million beds in 47 states.

SOURCE: Patheon Inc.